Glatiramer acetate combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.
| Reasons taken |
# of patients
Efficacy
|
Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Other | 5 |
|
1 | ||||
| Multiple Sclerosis MS | 3 | 0 |
See all 9 patients currently taking Glatiramer acetate
Mouse over the table for more information
See more information, including instructions, precautions, side effects, and interactions.
Report created on March 16, 2010.